Review



polyclonal knockout  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Alomone Labs polyclonal knockout
    Polyclonal Knockout, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 177 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal knockout/product/Alomone Labs
    Average 94 stars, based on 177 article reviews
    polyclonal knockout - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    94
    Alomone Labs polyclonal knockout
    Polyclonal Knockout, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal knockout/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    polyclonal knockout - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Bioss trpc1 primary antibodies
    Light microscopic examination of <t>TRPA1</t> immunoreactivity immunohistochemical staining in normal colon tissues. Arrows indicate areas of immunohistochemical staining.
    Trpc1 Primary Antibodies, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trpc1 primary antibodies/product/Bioss
    Average 94 stars, based on 1 article reviews
    trpc1 primary antibodies - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Alomone Labs rabbit polyclonal
    Features of the primary antibodies.
    Rabbit Polyclonal, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Alomone Labs rabbit polyclonal antibodies for trpc1
    Features of the primary antibodies.
    Rabbit Polyclonal Antibodies For Trpc1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibodies for trpc1/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal antibodies for trpc1 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology goat polyclonal anti hoatz c11orf88
    Features of the primary antibodies.
    Goat Polyclonal Anti Hoatz C11orf88, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/goat polyclonal anti hoatz c11orf88/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    goat polyclonal anti hoatz c11orf88 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher rabbit polyclonal anti-trpc1 antibody
    Features of the primary antibodies.
    Rabbit Polyclonal Anti Trpc1 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti-trpc1 antibody/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti-trpc1 antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    86
    Thermo Fisher rabbit polyclonal anti trpc1 antibody
    <t>TRPC1</t> and Orai3 are involved in carbachol (CCh)-evoked NF-κB activation in Orai1-KO cells. A, Orai1-KO HEK-293 cells (O1KO) transfected with either shTRPC1 (O1KO (shT1)), shTRPC6 (O1KO (shT6)), shOrai3 (O1KO (shO3)), or scramble plasmid (O1KO) were transfected with pNL3.2.NFkB-RE[NlucP/NF-kB-RE/Hygro]. Forty-eight hours later, cells were suspended in HBS containing 1 mM Ca 2+ and then stimulated for 5 h with 100 μM CCh or the vehicle (control) and lysed. Luciferase activity of the lysates was measured as described in the section. The luminescence in relative light units (RLUs) of unstimulated O1KO, O1KO(shT1), O1KO(shT6), and O1KO(shO3) HEK-293 cells were 598,259 ± 47,521, 601,025 ± 51,248, 599,987 ± 32,581, and 601,277 ± 39,985, respectively). B, O1KO, O1KO (shT1), and O1KO (shT6) HEK-293 cells were lysed and then subjected to 10% SDS-PAGE and Western blotting with anti-TRPC1 ( left panels ) or anti-TRPC6 ( right panels ) antibody. Membranes were reprobed with the anti-β-actin antibody for protein loading control. Molecular masses indicated on the right were determined using molecular-mass markers run in the same gel. Blots are representative of four separate experiments, and intensity of TRPC1 and TRPC6 bands was normalized to β-actin and quantified ( bar graph ). C, WT HEK-293 cells (WT), WT cells transfected with shOrai3 (shO3), O1KO cells, O1KO cells transfected with shOrai3 (O1KO (shO3)), and Orai1/Orai2/Orai3 triple-KO cells (TKO) transfected with pNL3.2.NFkB-RE[NlucP/NF-kB-RE/Hygro]. Forty-eight hours later, cells were suspended in HBS containing 1 mM Ca 2+ and stimulated for 5 h with 100 μM CCh or the vehicle (control) and lysed. Luciferase activity was measured as described in the section. The luminescence in RLUs of unstimulated WT, O1KO, O1KO(shO3), and TKO HEK-293 cells were 610,982 ± 48,875, 607,588 ± 47,510, 592,115 ± 37,514, and 597,323 ± 37,899, respectively. D, WT HEK-293 cells (WT) and WT cells transfected with shOrai3 (shO3) were lysed and subjected to 10% SDS-PAGE and Western blotting with anti-Orai3 antibody. Membranes were reprobed with the anti-β-actin antibody for protein loading control. Molecular masses indicated on the right were determined using molecular-mass markers run in the same gel. Blots are representative of four separate experiments, and intensity of Orai3 bands was normalized to β-actin and quantified ( bar graph ). E, WT, O1KO, TKO, and O1KO (shO3) HEK-293 cells were lysed and then subjected to 10% SDS-PAGE and Western blotting with anti-Orai3. Membranes were reprobed with the anti-β-actin antibody for protein loading control. Molecular masses indicated on the right were determined using molecular-mass markers run in the same gel. Blots are representative of four separate experiments, and intensity of Orai3 bands was normalized to β-actin and quantified ( bar graph ). For A, from left to right , n = 18, 14, 18, 13, 18, 12, 18, and 13; for C, from left to right , n = 30, 24, 12, 12, 18, 13, 18, 14, 18, and 12; n values correspond to separate experiments. Scatter plots are represented as mean ± SEM and were statistically analyzed using Kruskal–Wallis test with multiple comparisons (Dunn's test). ∗ p < 0.05 and ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001 as compared with CCh-treated O1KO HEK-293 cells ( A ) or CCh-treated WT HEK-293 cells ( C ). $ p < 0.05, $$ p < 0.01, and $$$$ p < 0 .0001 as compared with their respective control (untreated) cells. HBS, Hepes-buffered saline; HEK-293, human embryonic kidney 293 cell line.
    Rabbit Polyclonal Anti Trpc1 Antibody, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti trpc1 antibody/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    rabbit polyclonal anti trpc1 antibody - by Bioz Stars, 2026-02
    86/100 stars
      Buy from Supplier

    94
    Alomone Labs polyclonal trpc1 antibody
    (A) Nonselective TRPC channel blockers SKF96365 (30 µM) and 2-APB (100 µM) reduced the DHPG-induced inward current. (B) Time courses of the effects of SKF96365 (black circles, 30 µM, n = 4) and 2-APB (gray circles, 100 µM, n = 5) on the DHPG-induced inward current. A black bar indicates the time of drug application. (C) A TRPC3 blocker Pyr3 (30 µM) suppressed the DHPG-induced inward current in PCs (right) but not in MLIs (left). (D) Time courses of the effects of Pyr3 on the DHPG-induced inward current in MLIs (white circles, n = 5) and in PCs (black circles, n = 6). (E) Dialysis of an <t>anti-TRPC1</t> antibody (1∶200 dilution) into MLIs through patch pipettes markedly reduced the DHPG-induced inward current (left), while dialysis of the antibody preincubated with its antigenic peptide did not (right). The current traces were obtained at the indicated time points (2 and 12 min) after establishing whole-cell configuration. (F) Time course of the effect of the anti-TRPC1 antibody on the DHPG-induced inward current (black circles, n = 6) compared to control experiments using the antibody preincubated with its antigenic peptide (white circles, n = 5).
    Polyclonal Trpc1 Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal trpc1 antibody/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    polyclonal trpc1 antibody - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    Image Search Results


    Light microscopic examination of TRPA1 immunoreactivity immunohistochemical staining in normal colon tissues. Arrows indicate areas of immunohistochemical staining.

    Journal: Cancer Management and Research

    Article Title: Investigation of Trpa1 and Trpc1 Immunreactivities in Colon Adenocarcinomas

    doi: 10.2147/CMAR.S447549

    Figure Lengend Snippet: Light microscopic examination of TRPA1 immunoreactivity immunohistochemical staining in normal colon tissues. Arrows indicate areas of immunohistochemical staining.

    Article Snippet: Thereafter, the tissues were incubated with TRPA1 and TRPC1 primary antibodies (TRPA1 Polyclonal Antibody, Elabscince, E-AB-62987, Texas, USA and TRPC1 Polyclonal antibody, bs-10404R, Biossusa, USA) diluted at 1:200 for 60 minutes at room temperature in a humid environment.

    Techniques: Immunohistochemical staining, Staining

    Light microscopic examination of TRPA1 immunoreactivity immunohistochemical staining in Low-Grade colon adenocarcinoma tissues. Arrows indicate areas of immunohistochemical staining.

    Journal: Cancer Management and Research

    Article Title: Investigation of Trpa1 and Trpc1 Immunreactivities in Colon Adenocarcinomas

    doi: 10.2147/CMAR.S447549

    Figure Lengend Snippet: Light microscopic examination of TRPA1 immunoreactivity immunohistochemical staining in Low-Grade colon adenocarcinoma tissues. Arrows indicate areas of immunohistochemical staining.

    Article Snippet: Thereafter, the tissues were incubated with TRPA1 and TRPC1 primary antibodies (TRPA1 Polyclonal Antibody, Elabscince, E-AB-62987, Texas, USA and TRPC1 Polyclonal antibody, bs-10404R, Biossusa, USA) diluted at 1:200 for 60 minutes at room temperature in a humid environment.

    Techniques: Immunohistochemical staining, Staining

    Light microscopic examination of TRPA1 immunoreactivity immunohistochemical staining in High-Grade colon adenocarcinoma tissues. Arrows indicate areas of immunohistochemical staining.

    Journal: Cancer Management and Research

    Article Title: Investigation of Trpa1 and Trpc1 Immunreactivities in Colon Adenocarcinomas

    doi: 10.2147/CMAR.S447549

    Figure Lengend Snippet: Light microscopic examination of TRPA1 immunoreactivity immunohistochemical staining in High-Grade colon adenocarcinoma tissues. Arrows indicate areas of immunohistochemical staining.

    Article Snippet: Thereafter, the tissues were incubated with TRPA1 and TRPC1 primary antibodies (TRPA1 Polyclonal Antibody, Elabscince, E-AB-62987, Texas, USA and TRPC1 Polyclonal antibody, bs-10404R, Biossusa, USA) diluted at 1:200 for 60 minutes at room temperature in a humid environment.

    Techniques: Immunohistochemical staining, Staining

     TRPA1  and  TRPC1  Immunoreactivity Histoscore

    Journal: Cancer Management and Research

    Article Title: Investigation of Trpa1 and Trpc1 Immunreactivities in Colon Adenocarcinomas

    doi: 10.2147/CMAR.S447549

    Figure Lengend Snippet: TRPA1 and TRPC1 Immunoreactivity Histoscore

    Article Snippet: Thereafter, the tissues were incubated with TRPA1 and TRPC1 primary antibodies (TRPA1 Polyclonal Antibody, Elabscince, E-AB-62987, Texas, USA and TRPC1 Polyclonal antibody, bs-10404R, Biossusa, USA) diluted at 1:200 for 60 minutes at room temperature in a humid environment.

    Techniques: Control

    TRPA1 immunoreactivity.

    Journal: Cancer Management and Research

    Article Title: Investigation of Trpa1 and Trpc1 Immunreactivities in Colon Adenocarcinomas

    doi: 10.2147/CMAR.S447549

    Figure Lengend Snippet: TRPA1 immunoreactivity.

    Article Snippet: Thereafter, the tissues were incubated with TRPA1 and TRPC1 primary antibodies (TRPA1 Polyclonal Antibody, Elabscince, E-AB-62987, Texas, USA and TRPC1 Polyclonal antibody, bs-10404R, Biossusa, USA) diluted at 1:200 for 60 minutes at room temperature in a humid environment.

    Techniques:

    Light microscopic examination of TRPC1 immunoreactivity immunohistochemical staining in normal colon tissues. Arrows indicate areas of immunohistochemical staining.

    Journal: Cancer Management and Research

    Article Title: Investigation of Trpa1 and Trpc1 Immunreactivities in Colon Adenocarcinomas

    doi: 10.2147/CMAR.S447549

    Figure Lengend Snippet: Light microscopic examination of TRPC1 immunoreactivity immunohistochemical staining in normal colon tissues. Arrows indicate areas of immunohistochemical staining.

    Article Snippet: Thereafter, the tissues were incubated with TRPA1 and TRPC1 primary antibodies (TRPA1 Polyclonal Antibody, Elabscince, E-AB-62987, Texas, USA and TRPC1 Polyclonal antibody, bs-10404R, Biossusa, USA) diluted at 1:200 for 60 minutes at room temperature in a humid environment.

    Techniques: Immunohistochemical staining, Staining

    Light microscopic examination of TRPC1 immunoreactivity immunohistochemical staining in Low-Grade colon adenocarcinoma tissues. Arrows indicate areas of immunohistochemical staining.

    Journal: Cancer Management and Research

    Article Title: Investigation of Trpa1 and Trpc1 Immunreactivities in Colon Adenocarcinomas

    doi: 10.2147/CMAR.S447549

    Figure Lengend Snippet: Light microscopic examination of TRPC1 immunoreactivity immunohistochemical staining in Low-Grade colon adenocarcinoma tissues. Arrows indicate areas of immunohistochemical staining.

    Article Snippet: Thereafter, the tissues were incubated with TRPA1 and TRPC1 primary antibodies (TRPA1 Polyclonal Antibody, Elabscince, E-AB-62987, Texas, USA and TRPC1 Polyclonal antibody, bs-10404R, Biossusa, USA) diluted at 1:200 for 60 minutes at room temperature in a humid environment.

    Techniques: Immunohistochemical staining, Staining

    Light microscopic examination of TRPC1 immunoreactivity immunohistochemical staining in High-Grade colon adenocarcinoma tissues. Arrows indicate areas of immunohistochemical staining.

    Journal: Cancer Management and Research

    Article Title: Investigation of Trpa1 and Trpc1 Immunreactivities in Colon Adenocarcinomas

    doi: 10.2147/CMAR.S447549

    Figure Lengend Snippet: Light microscopic examination of TRPC1 immunoreactivity immunohistochemical staining in High-Grade colon adenocarcinoma tissues. Arrows indicate areas of immunohistochemical staining.

    Article Snippet: Thereafter, the tissues were incubated with TRPA1 and TRPC1 primary antibodies (TRPA1 Polyclonal Antibody, Elabscince, E-AB-62987, Texas, USA and TRPC1 Polyclonal antibody, bs-10404R, Biossusa, USA) diluted at 1:200 for 60 minutes at room temperature in a humid environment.

    Techniques: Immunohistochemical staining, Staining

    TRPC1 immunoreactivity.

    Journal: Cancer Management and Research

    Article Title: Investigation of Trpa1 and Trpc1 Immunreactivities in Colon Adenocarcinomas

    doi: 10.2147/CMAR.S447549

    Figure Lengend Snippet: TRPC1 immunoreactivity.

    Article Snippet: Thereafter, the tissues were incubated with TRPA1 and TRPC1 primary antibodies (TRPA1 Polyclonal Antibody, Elabscince, E-AB-62987, Texas, USA and TRPC1 Polyclonal antibody, bs-10404R, Biossusa, USA) diluted at 1:200 for 60 minutes at room temperature in a humid environment.

    Techniques:

    Features of the primary antibodies.

    Journal: International Journal of Molecular Sciences

    Article Title: Selective Assembly of TRPC Channels in the Rat Retina during Photoreceptor Degeneration

    doi: 10.3390/ijms25137251

    Figure Lengend Snippet: Features of the primary antibodies.

    Article Snippet: TRPC1 , Intracellular aa’ of human TRPC1 , Rabbit Polyclonal , Alomone Labs (Jerusalem, Israel, #ACC-010 , IC: 1:500 PLA 3 : 1:400.

    Techniques: Isolation

    TRPC1 and Orai3 are involved in carbachol (CCh)-evoked NF-κB activation in Orai1-KO cells. A, Orai1-KO HEK-293 cells (O1KO) transfected with either shTRPC1 (O1KO (shT1)), shTRPC6 (O1KO (shT6)), shOrai3 (O1KO (shO3)), or scramble plasmid (O1KO) were transfected with pNL3.2.NFkB-RE[NlucP/NF-kB-RE/Hygro]. Forty-eight hours later, cells were suspended in HBS containing 1 mM Ca 2+ and then stimulated for 5 h with 100 μM CCh or the vehicle (control) and lysed. Luciferase activity of the lysates was measured as described in the section. The luminescence in relative light units (RLUs) of unstimulated O1KO, O1KO(shT1), O1KO(shT6), and O1KO(shO3) HEK-293 cells were 598,259 ± 47,521, 601,025 ± 51,248, 599,987 ± 32,581, and 601,277 ± 39,985, respectively). B, O1KO, O1KO (shT1), and O1KO (shT6) HEK-293 cells were lysed and then subjected to 10% SDS-PAGE and Western blotting with anti-TRPC1 ( left panels ) or anti-TRPC6 ( right panels ) antibody. Membranes were reprobed with the anti-β-actin antibody for protein loading control. Molecular masses indicated on the right were determined using molecular-mass markers run in the same gel. Blots are representative of four separate experiments, and intensity of TRPC1 and TRPC6 bands was normalized to β-actin and quantified ( bar graph ). C, WT HEK-293 cells (WT), WT cells transfected with shOrai3 (shO3), O1KO cells, O1KO cells transfected with shOrai3 (O1KO (shO3)), and Orai1/Orai2/Orai3 triple-KO cells (TKO) transfected with pNL3.2.NFkB-RE[NlucP/NF-kB-RE/Hygro]. Forty-eight hours later, cells were suspended in HBS containing 1 mM Ca 2+ and stimulated for 5 h with 100 μM CCh or the vehicle (control) and lysed. Luciferase activity was measured as described in the section. The luminescence in RLUs of unstimulated WT, O1KO, O1KO(shO3), and TKO HEK-293 cells were 610,982 ± 48,875, 607,588 ± 47,510, 592,115 ± 37,514, and 597,323 ± 37,899, respectively. D, WT HEK-293 cells (WT) and WT cells transfected with shOrai3 (shO3) were lysed and subjected to 10% SDS-PAGE and Western blotting with anti-Orai3 antibody. Membranes were reprobed with the anti-β-actin antibody for protein loading control. Molecular masses indicated on the right were determined using molecular-mass markers run in the same gel. Blots are representative of four separate experiments, and intensity of Orai3 bands was normalized to β-actin and quantified ( bar graph ). E, WT, O1KO, TKO, and O1KO (shO3) HEK-293 cells were lysed and then subjected to 10% SDS-PAGE and Western blotting with anti-Orai3. Membranes were reprobed with the anti-β-actin antibody for protein loading control. Molecular masses indicated on the right were determined using molecular-mass markers run in the same gel. Blots are representative of four separate experiments, and intensity of Orai3 bands was normalized to β-actin and quantified ( bar graph ). For A, from left to right , n = 18, 14, 18, 13, 18, 12, 18, and 13; for C, from left to right , n = 30, 24, 12, 12, 18, 13, 18, 14, 18, and 12; n values correspond to separate experiments. Scatter plots are represented as mean ± SEM and were statistically analyzed using Kruskal–Wallis test with multiple comparisons (Dunn's test). ∗ p < 0.05 and ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001 as compared with CCh-treated O1KO HEK-293 cells ( A ) or CCh-treated WT HEK-293 cells ( C ). $ p < 0.05, $$ p < 0.01, and $$$$ p < 0 .0001 as compared with their respective control (untreated) cells. HBS, Hepes-buffered saline; HEK-293, human embryonic kidney 293 cell line.

    Journal: The Journal of Biological Chemistry

    Article Title: The store-operated Ca 2+ channel Orai1α is required for agonist-evoked NF-κB activation by a mechanism dependent on PKCβ2

    doi: 10.1016/j.jbc.2023.102882

    Figure Lengend Snippet: TRPC1 and Orai3 are involved in carbachol (CCh)-evoked NF-κB activation in Orai1-KO cells. A, Orai1-KO HEK-293 cells (O1KO) transfected with either shTRPC1 (O1KO (shT1)), shTRPC6 (O1KO (shT6)), shOrai3 (O1KO (shO3)), or scramble plasmid (O1KO) were transfected with pNL3.2.NFkB-RE[NlucP/NF-kB-RE/Hygro]. Forty-eight hours later, cells were suspended in HBS containing 1 mM Ca 2+ and then stimulated for 5 h with 100 μM CCh or the vehicle (control) and lysed. Luciferase activity of the lysates was measured as described in the section. The luminescence in relative light units (RLUs) of unstimulated O1KO, O1KO(shT1), O1KO(shT6), and O1KO(shO3) HEK-293 cells were 598,259 ± 47,521, 601,025 ± 51,248, 599,987 ± 32,581, and 601,277 ± 39,985, respectively). B, O1KO, O1KO (shT1), and O1KO (shT6) HEK-293 cells were lysed and then subjected to 10% SDS-PAGE and Western blotting with anti-TRPC1 ( left panels ) or anti-TRPC6 ( right panels ) antibody. Membranes were reprobed with the anti-β-actin antibody for protein loading control. Molecular masses indicated on the right were determined using molecular-mass markers run in the same gel. Blots are representative of four separate experiments, and intensity of TRPC1 and TRPC6 bands was normalized to β-actin and quantified ( bar graph ). C, WT HEK-293 cells (WT), WT cells transfected with shOrai3 (shO3), O1KO cells, O1KO cells transfected with shOrai3 (O1KO (shO3)), and Orai1/Orai2/Orai3 triple-KO cells (TKO) transfected with pNL3.2.NFkB-RE[NlucP/NF-kB-RE/Hygro]. Forty-eight hours later, cells were suspended in HBS containing 1 mM Ca 2+ and stimulated for 5 h with 100 μM CCh or the vehicle (control) and lysed. Luciferase activity was measured as described in the section. The luminescence in RLUs of unstimulated WT, O1KO, O1KO(shO3), and TKO HEK-293 cells were 610,982 ± 48,875, 607,588 ± 47,510, 592,115 ± 37,514, and 597,323 ± 37,899, respectively. D, WT HEK-293 cells (WT) and WT cells transfected with shOrai3 (shO3) were lysed and subjected to 10% SDS-PAGE and Western blotting with anti-Orai3 antibody. Membranes were reprobed with the anti-β-actin antibody for protein loading control. Molecular masses indicated on the right were determined using molecular-mass markers run in the same gel. Blots are representative of four separate experiments, and intensity of Orai3 bands was normalized to β-actin and quantified ( bar graph ). E, WT, O1KO, TKO, and O1KO (shO3) HEK-293 cells were lysed and then subjected to 10% SDS-PAGE and Western blotting with anti-Orai3. Membranes were reprobed with the anti-β-actin antibody for protein loading control. Molecular masses indicated on the right were determined using molecular-mass markers run in the same gel. Blots are representative of four separate experiments, and intensity of Orai3 bands was normalized to β-actin and quantified ( bar graph ). For A, from left to right , n = 18, 14, 18, 13, 18, 12, 18, and 13; for C, from left to right , n = 30, 24, 12, 12, 18, 13, 18, 14, 18, and 12; n values correspond to separate experiments. Scatter plots are represented as mean ± SEM and were statistically analyzed using Kruskal–Wallis test with multiple comparisons (Dunn's test). ∗ p < 0.05 and ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001 as compared with CCh-treated O1KO HEK-293 cells ( A ) or CCh-treated WT HEK-293 cells ( C ). $ p < 0.05, $$ p < 0.01, and $$$$ p < 0 .0001 as compared with their respective control (untreated) cells. HBS, Hepes-buffered saline; HEK-293, human embryonic kidney 293 cell line.

    Article Snippet: High-glucose Dulbecco’s modified Eagle’s medium, fetal bovine serum, trypsin, penicillin/streptomycin, TRIzol reagent, qRT–PCR primers, high-capacity complementary DNA reverse transcription kit, SYBR Green PowerUp, rabbit polyclonal anti-TRPC1 antibody (catalog number: PA577303, epitope: amino acids 557–571 of human TRPC1), Clean-Blot IP detection reagent, and SuperSignal West Dura extended duration substrate reagent, and Pierce BCA protein assay kit were purchased from Thermo Fisher Scientific.

    Techniques: Activation Assay, Transfection, Plasmid Preparation, Luciferase, Activity Assay, SDS Page, Western Blot

    (A) Nonselective TRPC channel blockers SKF96365 (30 µM) and 2-APB (100 µM) reduced the DHPG-induced inward current. (B) Time courses of the effects of SKF96365 (black circles, 30 µM, n = 4) and 2-APB (gray circles, 100 µM, n = 5) on the DHPG-induced inward current. A black bar indicates the time of drug application. (C) A TRPC3 blocker Pyr3 (30 µM) suppressed the DHPG-induced inward current in PCs (right) but not in MLIs (left). (D) Time courses of the effects of Pyr3 on the DHPG-induced inward current in MLIs (white circles, n = 5) and in PCs (black circles, n = 6). (E) Dialysis of an anti-TRPC1 antibody (1∶200 dilution) into MLIs through patch pipettes markedly reduced the DHPG-induced inward current (left), while dialysis of the antibody preincubated with its antigenic peptide did not (right). The current traces were obtained at the indicated time points (2 and 12 min) after establishing whole-cell configuration. (F) Time course of the effect of the anti-TRPC1 antibody on the DHPG-induced inward current (black circles, n = 6) compared to control experiments using the antibody preincubated with its antigenic peptide (white circles, n = 5).

    Journal: PLoS ONE

    Article Title: mGluR1-Mediated Excitation of Cerebellar GABAergic Interneurons Requires Both G Protein-Dependent and Src–ERK1/2-Dependent Signaling Pathways

    doi: 10.1371/journal.pone.0106316

    Figure Lengend Snippet: (A) Nonselective TRPC channel blockers SKF96365 (30 µM) and 2-APB (100 µM) reduced the DHPG-induced inward current. (B) Time courses of the effects of SKF96365 (black circles, 30 µM, n = 4) and 2-APB (gray circles, 100 µM, n = 5) on the DHPG-induced inward current. A black bar indicates the time of drug application. (C) A TRPC3 blocker Pyr3 (30 µM) suppressed the DHPG-induced inward current in PCs (right) but not in MLIs (left). (D) Time courses of the effects of Pyr3 on the DHPG-induced inward current in MLIs (white circles, n = 5) and in PCs (black circles, n = 6). (E) Dialysis of an anti-TRPC1 antibody (1∶200 dilution) into MLIs through patch pipettes markedly reduced the DHPG-induced inward current (left), while dialysis of the antibody preincubated with its antigenic peptide did not (right). The current traces were obtained at the indicated time points (2 and 12 min) after establishing whole-cell configuration. (F) Time course of the effect of the anti-TRPC1 antibody on the DHPG-induced inward current (black circles, n = 6) compared to control experiments using the antibody preincubated with its antigenic peptide (white circles, n = 5).

    Article Snippet: DHPG, 7-(hydroxyimino)cyclopropa-[b]chromen-1a-carboxylate ethyl ester (CPCCOEt), ( S )-(+)-α-amino-4-carboxy-2-methylbenzeneacetic acid (LY367385), 1-[2-(4-methoxyphenyl)-2-[3-(4-methoxyphenyl)propoxy]ethyl-1 H -imidazole (SKF96365), (E)-2-cyano-3-(3,4-dihydrophenyl)-N-(phenylmethyl)-2-propenamide (AG490), (-)-bicuculline methochloride, 3-(4-chlorophenyl) 1-(1,1-dimethylethyl)-1 H -pyrazolo[3,4-d]pyrimidin-4-amine (PP2), 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin -4-amine (PP3), SR95531 (gabazine), U73122, U73343, and SL327 were obtained from Tocris Bioscience (Bristol, UK); 2-aminoethoxydiphenylborane (2-APB) was obtained from Abcam Biochemicals (Cambridge, UK); A polyclonal TRPC1 antibody and its control antigen, amino acid residues 557-571 of human TRPC1 were obtained from Alomone Labs (Cat#: ACC-010, Jerusalem, Israel).

    Techniques:

    (A) Representative traces under control conditions and in the presence of the Src tyrosine kinase inhibitor PP2 (30 µM) and the inactive PP2 analog PP3 (10 µM) are shown. Average traces were obtained from three continuous current events. (B) Time courses of the effects of PP2 and PP3 on the DHPG-induced inward current. The DHPG-current was suppressed by PP2 (black circles, n = 5) but not by PP3 (white circles, n = 4). A black bar indicates the time period of drug application. (C) The G protein-independent component of the DHPG-induced inward current was blocked by the Src tyrosine kinase inhibitor PP2 (30 µM). The DHPG-induced currents were recorded by whole-cell recordings with patch pipettes containing 1 mM GDPβS. The gray line indicates the average percent value during 12–16 min (63%). (D) MEK inhibitors PD98059 (10 µM) and SL327 (10 µM) reduced the DHPG-induced inward current. Averaged traces obtained from three continuous current events are shown. (E) Time courses of the effects of PD98059 (black circles, 10 µM, n = 5) and SL327 (gray circles, 10 µM, n = 4) on the DHPG-induced inward current ( n = 5). A black bar indicates the time point for application of the drugs. (F) Schematic diagram of signaling pathways required for the induction of mGluR1-mediated inward current in MLIs. The activation of mGluR1 opens TRPC1 channels through both G protein-dependent and G-protein-independent Src–ERK1/2 signaling pathways. DAG, diacylglycerol.

    Journal: PLoS ONE

    Article Title: mGluR1-Mediated Excitation of Cerebellar GABAergic Interneurons Requires Both G Protein-Dependent and Src–ERK1/2-Dependent Signaling Pathways

    doi: 10.1371/journal.pone.0106316

    Figure Lengend Snippet: (A) Representative traces under control conditions and in the presence of the Src tyrosine kinase inhibitor PP2 (30 µM) and the inactive PP2 analog PP3 (10 µM) are shown. Average traces were obtained from three continuous current events. (B) Time courses of the effects of PP2 and PP3 on the DHPG-induced inward current. The DHPG-current was suppressed by PP2 (black circles, n = 5) but not by PP3 (white circles, n = 4). A black bar indicates the time period of drug application. (C) The G protein-independent component of the DHPG-induced inward current was blocked by the Src tyrosine kinase inhibitor PP2 (30 µM). The DHPG-induced currents were recorded by whole-cell recordings with patch pipettes containing 1 mM GDPβS. The gray line indicates the average percent value during 12–16 min (63%). (D) MEK inhibitors PD98059 (10 µM) and SL327 (10 µM) reduced the DHPG-induced inward current. Averaged traces obtained from three continuous current events are shown. (E) Time courses of the effects of PD98059 (black circles, 10 µM, n = 5) and SL327 (gray circles, 10 µM, n = 4) on the DHPG-induced inward current ( n = 5). A black bar indicates the time point for application of the drugs. (F) Schematic diagram of signaling pathways required for the induction of mGluR1-mediated inward current in MLIs. The activation of mGluR1 opens TRPC1 channels through both G protein-dependent and G-protein-independent Src–ERK1/2 signaling pathways. DAG, diacylglycerol.

    Article Snippet: DHPG, 7-(hydroxyimino)cyclopropa-[b]chromen-1a-carboxylate ethyl ester (CPCCOEt), ( S )-(+)-α-amino-4-carboxy-2-methylbenzeneacetic acid (LY367385), 1-[2-(4-methoxyphenyl)-2-[3-(4-methoxyphenyl)propoxy]ethyl-1 H -imidazole (SKF96365), (E)-2-cyano-3-(3,4-dihydrophenyl)-N-(phenylmethyl)-2-propenamide (AG490), (-)-bicuculline methochloride, 3-(4-chlorophenyl) 1-(1,1-dimethylethyl)-1 H -pyrazolo[3,4-d]pyrimidin-4-amine (PP2), 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin -4-amine (PP3), SR95531 (gabazine), U73122, U73343, and SL327 were obtained from Tocris Bioscience (Bristol, UK); 2-aminoethoxydiphenylborane (2-APB) was obtained from Abcam Biochemicals (Cambridge, UK); A polyclonal TRPC1 antibody and its control antigen, amino acid residues 557-571 of human TRPC1 were obtained from Alomone Labs (Cat#: ACC-010, Jerusalem, Israel).

    Techniques: Activation Assay